| Patents for C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems (11,865) |
|---|
| 01/30/2003 | WO2003007931A1 Sulfonamide derivatives |
| 01/30/2003 | US20030023092 Reacting tetrahydrofuran compound with oxophilic electrophilic reagent to produce oxazoline compound |
| 01/30/2003 | US20030022893 Hydroxamic and carboxylic acid derivatives |
| 01/29/2003 | EP1279519A2 Image forming material and ammonium compound |
| 01/29/2003 | EP1278758A1 Combretastatin a-1 phosphate and combretastatin b-1 phosphate prodrugs |
| 01/29/2003 | EP1278722A1 Aryl and heteroaryl sulfonates |
| 01/29/2003 | CN1394203A Piperidine and piperazine derivatives which function as 5-HT2A receptor antagonists |
| 01/28/2003 | US6512135 2-methyl-3-(protected hydroxy) benzyl chloride; use making nelfinavir mesylate |
| 01/28/2003 | US6511987 Heterocyclic derivatives that bind to the benzodiazepine site of GABAA receptors for treatment of central nervous system disorders |
| 01/28/2003 | US6511980 For therapy of gastrointestinal reflux disorders, eating disorders leading to obesity and irritable bowel disorder |
| 01/23/2003 | WO2002088088A9 Process for preparing 1-methyl-1,2,3,4-tetrahydroisoquinoline or a salt thereof |
| 01/23/2003 | WO2002034760A3 Compounds and methods |
| 01/23/2003 | US20030018059 Antiinflammatory agents; antihistamines; antiallergens |
| 01/23/2003 | CA2417156A1 3,4-dihydroisoquinoline derivative compound and a pharmaceutical agent comprising it as active ingredient |
| 01/22/2003 | EP1277740A1 Inhibitors of p38 |
| 01/22/2003 | EP1277729A1 Ppar (gamma) modulators |
| 01/22/2003 | EP1276722A1 Naphthamidine urokinase inhibitors |
| 01/22/2003 | EP0775115B1 Dimeric arylisoquinoline alkaloids and synthesis methods thereof |
| 01/22/2003 | EP0646115B1 Heterocyclic-cyclic amine derivatives |
| 01/21/2003 | US6509467 Of iminium salts using transition metal complex catalyst |
| 01/21/2003 | US6509351 A method of inhibiting TNF- alpha in a patient in need thereof which comprises administering to said patient an effective amount of a compound for inflamation |
| 01/21/2003 | US6509344 Indenoisoquinolines as antineoplastic agents |
| 01/21/2003 | US6508753 Chiral ligands for asymmetric catalysis |
| 01/16/2003 | WO2002070467B1 Derivatives of diphenylurea, diphenyloxalic acid diamide and diphenylsulfuric acid diamide and their use as medicaments |
| 01/16/2003 | US20030013847 Pyruvate derivatives |
| 01/16/2003 | US20030013846 Cytoprotective agents |
| 01/16/2003 | US20030013725 Amino acid derivatives |
| 01/16/2003 | US20030013721 Antiinflammatory agents; immunology; cardiovascular disorders; rheumatic disorders |
| 01/16/2003 | US20030013715 Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases |
| 01/16/2003 | US20030013714 Sleep disorders; eating disorders; sexual disorders; hypotensive agents |
| 01/16/2003 | US20030013657 Reducing oxidation stresses; central nervous system disorders; antiinflammatory agents |
| 01/16/2003 | US20030013656 Reducing oxidation stresses; central nervous system disorders; antiinflammatory agents |
| 01/16/2003 | US20030013041 Write-once optical data carrier |
| 01/15/2003 | EP1274687A1 1,2,3,4- tetrahydroisoquinoline derivatives |
| 01/15/2003 | CN1391570A Phenyl-and pyridyl-tetrahydro-pyridines having TNF inhibiting activity |
| 01/15/2003 | CN1391565A Benzophenones as inhibitors of reverse transcriptase |
| 01/15/2003 | CN1391555A Benzamides and related inhibitors of factor Xa |
| 01/15/2003 | CN1391473A VLA-4 inhibitor compounds |
| 01/15/2003 | CN1391469A Npyy5拮抗剂 Npyy5 antagonist |
| 01/14/2003 | US6506773 Hydroxamic and carboxylic acid derivatives |
| 01/14/2003 | US6506769 Heterocyclic compounds useful as inhibitors of tyrosine kinases |
| 01/14/2003 | US6506759 Retroviral protease inhibitors |
| 01/14/2003 | CA2231540C Color-safe bleach boosters, compositions and laundry methods employing same |
| 01/09/2003 | WO2003002519A1 Phenol derivatives and their use in medicaments |
| 01/09/2003 | WO2002080152A3 Optical data carrier that contains a heterocyclic azo dye as the light-absorbing compound in the information layer |
| 01/09/2003 | US20030008896 Isoquinolinone derivatives |
| 01/09/2003 | US20030008895 Prostaglandin agonists |
| 01/09/2003 | US20030008884 Fungicidal phenyl (thio) urea and phenyl (thio) carbamate derivatives |
| 01/09/2003 | US20030008234 Optical data carrier comprising a cyanine dye as light-absorbent compound in the information layer |
| 01/09/2003 | US20030006516 Radiation transparent subsrates; reflecting layer |
| 01/08/2003 | EP1273298A2 Ritonavir in combination with an additional HIV protease inhibitor for treating aids |
| 01/08/2003 | EP1272485A1 Novel 1,2,3,4-tetrahydrosioquinoline, their preparation method and their use as fungicides |
| 01/08/2003 | EP1077945B1 Isoquinolines as urokinase inhibitors |
| 01/08/2003 | EP0996439B1 Beta-alkoxyacrylates against malaria |
| 01/08/2003 | EP0863878B1 Cyclic nitrones and pharmaceutical compositions containing them |
| 01/08/2003 | CN1390217A Bicyclic and tricyclic heteroaromatic compounds |
| 01/08/2003 | CN1390210A Process for preparing oxazolines from tetrahydrofurans |
| 01/08/2003 | CN1390206A Inhibitors of factor Xa |
| 01/08/2003 | CN1390205A Novel compound |
| 01/08/2003 | CN1098260C 2,4-diaminopyrimidine derivatives |
| 01/07/2003 | US6504031 Enzyme inhibitor such as 6-(2-(1-isopropyl-1,2,3,4-tetrahydro -7-isoquinolinyl)ethenyl)-2-naphthalenecarboximidamide, used as angiogenesis inhibitors; antiarthritic, antiinflammatory and antitumor agents |
| 01/03/2003 | WO2003000181A2 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 01/03/2003 | WO2002088101A3 Inhibitors of bace |
| 01/03/2003 | CA2450475A1 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 01/02/2003 | WO2002002529A1 Bicyclic lactams and sulfonamides with 5-ht1a-affinity and use thereof for preventing and treating cerebral ischaemia |
| 01/02/2003 | US20030004339 Therapy for benign prostatic hyperplasia |
| 01/02/2003 | US20030003396 Reflection, protective or covering layers which can be written on or read by blue, red or infrared light |
| 01/02/2003 | EP1268466A1 Decahydro-isoquinolines |
| 01/02/2003 | EP1268432A1 ISOQUINOLONE INHIBITORS OF FACTOR Xa |
| 01/02/2003 | EP0804431B9 GLYCOPROTEIN IIb/IIIa ANTAGONISTS |
| 01/02/2003 | CA2414726A1 Bicyclic lactams and sulfonamides with 5-ht1a-affinity and use thereof for preventing and treating cerebral ischaemia |
| 01/01/2003 | CN1097591C Process for preparing pyrimidine derivatives |
| 12/31/2002 | US6500954 One pot process of bromination and nitration of isoquinoline to produce such as 5-bromo-8-nitroisoquinoline |
| 12/31/2002 | US6500841 Inhibitors of farnesyl-protein transferase |
| 12/31/2002 | US6500823 Energy deficiency of the cell caused by parp inhibition, in diabetes complications, in oxygen deficient status of the heart and brain, in neurodegenerative diseases, in the treatment of autoimmune and/or viral diseases |
| 12/31/2002 | US6500802 Peptidyl-2-amino-1-hydroxyalkanesulfonic acid cysteine protease inhibitors |
| 12/27/2002 | WO2002070473A3 Carboxamide derivatives as therapeutic agents |
| 12/27/2002 | WO2002046181A3 Abca-1 elevating compounds against coronary artery disease or atherosclerosis |
| 12/26/2002 | US20020198207 Novel Hexanoic acid derivatives |
| 12/26/2002 | US20020197561 Information layer comprises a light-absorbent compound that is a dye which cyclizes thermally |
| 12/26/2002 | US20020197439 Optical data storage medium containing a triazacyanine dye as the light-absorbing compound in the information layer |
| 12/19/2002 | WO2002101073A2 Aryl-benzimidazole compounds having antiinfective activity |
| 12/19/2002 | WO2002101007A2 Antipathogenic benzamide compounds |
| 12/19/2002 | WO2002100860A2 Heterocyclic compounds, method for preparing same and use thereof as medicines, in particular as anti-bacterial agents |
| 12/19/2002 | WO2002100852A1 Benzothiophene compounds having antiinfective activity |
| 12/19/2002 | WO2002100849A2 Novel nitriles useful as reversible inhibitors of cysteine proteases |
| 12/19/2002 | WO2002100848A1 Novel phenylalkyl diamine and amide analogs |
| 12/19/2002 | WO2002100845A1 Hv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
| 12/19/2002 | WO2002100844A2 Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
| 12/19/2002 | WO2002100832A1 Isoquinoline compounds having antiinfective activity |
| 12/19/2002 | WO2002100825A2 Anthranilic acid amides with a heteroarylsulfonyl side chain, and use thereof as antiarrhythmic active substances |
| 12/19/2002 | WO2002100822A1 Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ii diabetes |
| 12/19/2002 | WO2002100813A2 Modulators of peroxisome proliferator activated receptors |
| 12/19/2002 | WO2002100405A1 Isoquinoline inhibitors of p38 |
| 12/19/2002 | WO2002080161A3 Optical data carrier that contains a merocyanine dye as the light-absorbing compound in the information layer |
| 12/19/2002 | WO2002070541A3 Peptide deformylase inhibitors |
| 12/19/2002 | WO2002042248A3 Naphthalene derivatives |
| 12/19/2002 | US20020193595 Agonists of the melanocortin-4 receptor ("MC-4r"); useful treating obesity and type 2 diabetes |
| 12/19/2002 | US20020193578 Compounds having activity as inhibitors of cytochrome P450RAI |
| 12/19/2002 | US20020193432 Useful as modulators of the interaction between the receptor for advanced glycated end product and its ligands |